When using this form of gene editing, Cedars-Sinai scientists can more efficiently insert reporter genes that glow when a stem cell turns into a specific cell of the body. 5 billion cells of the heart.
The team foresees their findings being implemented in the regrowth of cells lost during heart attack. And this might tremendously benefit the patients who undergo these kinds of procedures.
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Continue Reading »